Andrea Pierantozzi
Research Subjects
Research Interests
Andrea Pierantozzi has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Roberta Pacifici
National Centre on Addiction and Doping, Istituto Superiore di Sanità, 00161 Rome, Italy
2 shared publications - Andrea Romagnoli
Department of Radiology, University of Rome Tor Vergata, Rome, Italy
1 shared publication - Claudia Mortali
National Centre on Addiction and Doping, Italian National Institute of Health, Rome, Italy
1 shared publication - Daniela Mantella
Department of Nephrology and Dialysis, Forlanini-San Camillo Hospital, Rome, Italy
1 shared publication - Daniela Sardella
Nephrology and Hypertension Unit, Ospedale Israelitico, Rome, Italy
1 shared publication - Daniele Spizzichino
Nephrology and Hypertension Unit, Ospedale Israelitico, Rome, Italy
1 shared publication
Latest Publications
- Open Access
- 6 June 2011
- Published by Springer Nature in BMC Pediatrics
- Vol. 11 (1) , 51
A survey of Italian and Spanish neonatologists and paediatricians regarding awareness of the diagnosis of FAS and FASD and maternal ethanol use during pregnancy
Ethanol is the most widely used drug in the world and a human teratogen whose consumption among women of childbearing age has been steadily increasing. There are no Italian or Spanish statistics on ethanol consumption during pregnancy nor any information regarding prevalence of fetal alcohol syndrome (FAS) and fetal alcohol spectrum disorders (FASD). There is also a reasonable suspicion that these two diseases are underdiagnosed by professionals from the above-reported countries. The objectives of this study were: 1) to evaluate the experience, knowledge and confidence of Italian and Spanish neonatologists and paediatricians with respect to the diagnosis of FAS and FASD, and 2) to evaluate professionals awareness of maternal drinking patterns during pregnancy.
- 6 June 2011
- Published by Springer Nature in BMC Pediatrics
- Vol. 11 (1) , 51
Open AccessA survey of Italian and Spanish neonatologists and paediatricians regarding awareness of the diagnosis of FAS and FASD and maternal ethanol use during pregnancy
Ethanol is the most widely used drug in the world and a human teratogen whose consumption among women of childbearing age has been steadily increasing. There are no Italian or Spanish statistics on ethanol consumption during pregnancy nor any information regarding prevalence of fetal alcohol syndrome (FAS) and fetal alcohol spectrum disorders (FASD). There is also a reasonable suspicion that these two diseases are underdiagnosed by professionals from the above-reported countries. The objectives of this study were: 1) to evaluate the experience, knowledge and confidence of Italian and Spanish neonatologists and paediatricians with respect to the diagnosis of FAS and FASD, and 2) to evaluate professionals awareness of maternal drinking patterns during pregnancy.
- Open Access
- 21 June 2010
- Published by Springer Nature in BMC Nephrology
- Vol. 11 (1) , 10
Risk factors of one year increment of coronary calcifications and survival in hemodialysis patients
Heart and coronary calcifications in hemodialysis patients are of very common occurrence and linked to cardiovascular events and mortality. Several studies have been published with similar results. Most of them were mainly cross-sectional and some of the prospective protocols were aimed to evaluate the results of the control of altered biochemical parameters of mineral disturbances with special regard to serum calcium, phosphate and CaxP with the use of calcium containing and calcium free phosphate chelating agents. The aim of the present study was to evaluate in hemodialysis patients classic and some non classic risk factors as predictors of calcification changes after one year and to evaluate the impact of progression on survival.
- 21 June 2010
- Published by Springer Nature in BMC Nephrology
- Vol. 11 (1) , 10
Open AccessRisk factors of one year increment of coronary calcifications and survival in hemodialysis patients
Heart and coronary calcifications in hemodialysis patients are of very common occurrence and linked to cardiovascular events and mortality. Several studies have been published with similar results. Most of them were mainly cross-sectional and some of the prospective protocols were aimed to evaluate the results of the control of altered biochemical parameters of mineral disturbances with special regard to serum calcium, phosphate and CaxP with the use of calcium containing and calcium free phosphate chelating agents. The aim of the present study was to evaluate in hemodialysis patients classic and some non classic risk factors as predictors of calcification changes after one year and to evaluate the impact of progression on survival.